Australia markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
353.95+0.49 (+0.14%)
At close: 04:00PM EST
353.66 -0.29 (-0.08%)
Pre-market: 08:57AM EST
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
10,504,000
6,795,000
5,988,187
3,109,322
Other short-term investments
274,500
729,900
670,710
698,972
Total cash
10,778,500
7,524,900
6,658,897
3,808,294
Net receivables
1,442,200
1,136,800
885,352
633,518
Inventory
460,600
353,100
280,777
167,502
Other current assets
74,400
187,200
308,353
213,515
Total current assets
12,681,300
9,014,800
7,825,026
4,609,314
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,483,100
2,320,400
2,074,678
1,437,620
Accumulated depreciation
-1,027,300
-896,000
-790,580
-692,540
Net property, plant and equipment
1,108,400
1,094,100
958,534
745,080
Goodwill
1,088,000
1,402,200
1,402,158
1,402,158
Intangible assets
603,600
400,000
400,000
400,000
Other long-term assets
1,422,700
986,900
683,311
371,098
Total non-current assets
5,469,600
4,417,700
3,926,782
3,709,151
Total assets
18,150,900
13,432,500
11,751,808
8,318,465
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
303,900
195,000
155,139
87,610
Accrued liabilities
1,788,400
1,266,900
1,135,394
946,041
Deferred revenues
159,600
171,700
191,519
62,332
Other current liabilities
62,500
49,800
83,470
37,680
Total current liabilities
2,430,600
1,873,600
1,560,110
1,204,522
Non-current liabilities
Deferred revenues
-
-
-
88,762
Other long-term liabilities
1,336,000
902,200
923,407
451,328
Total non-current liabilities
1,807,600
1,458,900
1,504,883
1,028,699
Total liabilities
4,238,200
3,332,500
3,064,993
2,233,221
Stockholders' equity
Common stock
2,600
2,500
2,599
2,589
Retained earnings
6,522,800
3,200,800
858,669
-1,852,978
Accumulated other comprehensive income
800
15,900
-68,480
-1,973
Total stockholders' equity
13,912,700
10,100,000
8,686,815
6,085,244
Total liabilities and stockholders' equity
18,150,900
13,432,500
11,751,808
8,318,465